QUOIN PHARMAC.ADR 60000 Depository Receipt · US74907L3006 · QNRX · A3EJL7 (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of QUOIN PHARMAC.ADR 60000

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

01.05.2026 20:00

Current Prices from QUOIN PHARMAC.ADR 60000

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	QNRX	USD	01.05.2026 20:00	6,21 USD	-0,27 USD -4,17 %
IEX	QNRX	USD	30.04.2026 19:52	6,45 USD	-

Share Float & Liquidity

Free Float 26,74 %

Shares Float 157.257,00

Shares Outstanding 588.166,00

Company Profile for QUOIN PHARMAC.ADR 60000 Depository Receipt

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.